Toliodium

Toliodium

SCHEMBL4178434

Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.Cc1ccc([I+]c2ccc(C)cc2)cc1.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F.O=P([O-])([O-])F

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.39
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.38
CYP3A4 P08684 1/20 0.37
TLR9 Q9NR96 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ACHE P22303 3/20 0.36
TDP1 Q9NUW8 1/20 0.36
GAA P10253 4/20 0.36
CA12 O43570 3/20 0.33
CA9 Q16790 2/20 0.33
CA1 P00915 2/20 0.33
HSD17B10 Q99714 1/20 0.33
CA2 P00918 1/20 0.33
CA3 P07451 1/20 0.33
CA6 P23280 1/20 0.33
CA5A P35218 1/20 0.33
CA7 P43166 1/20 0.33
CA5B Q9Y2D0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3689606 0.83 ALDH1A1 (0.36) LMNATSHRALDH1A1
Toliodium SCHEMBL125171 0.80 ACHE (0.57) LMNATSHRTLR9ACHETDP1
SCHEMBL31164243 0.78 SCN5A (0.40) HPGDLMNATSHRMEN1KMT2A
Toliodium SCHEMBL9634141 0.77 TLR9 (0.37) HPGDLMNACYP3A4TLR9ACHE
Toliodium SCHEMBL10780090 0.77 TLR9 (0.37) HPGDLMNACYP3A4TLR9ACHE
Toliodium SCHEMBL3284569 0.77 ACHE (0.53) LMNATSHRTLR9ACHETDP1
Toliodium SCHEMBL9296014 0.77 ACHE (0.53) LMNATSHRTLR9ACHETDP1
Toliodium SCHEMBL5408779 0.77 ACHE (0.53) LMNATSHRTLR9ACHETDP1
Toliodium SCHEMBL7743288 0.77 ACHE (0.53) LMNATSHRTLR9ACHETDP1
SCHEMBL8420072 0.77 ALDH1A1 (0.39) LMNATSHRMEN1KMT2AACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11999865-B2 UV curable composition for use in 3D printing BASF SE (DE) 2024-06-04 US disclosed
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING BASF SE (DE) 2022-03-03 US disclosed
US-20210395558-A1 UV CURABLE COMPOSITION FOR USE IN 3D PRINTING BASF SE (DE) 2021-12-23 US disclosed
EP-3541793-B1 PROCESS FOR THE MANUFACTURING OF TRIARYL-ALKYL BORATES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2021-03-31 EP disclosed
EP-3538534-B1 PROCESS FOR THE MANUFACTURING OF TRIARYL-ALKYL BORATES COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2020-09-16 EP disclosed
US-20090018230-A1 Yellow radiation curing inks CIBA CORP. 2009-01-15 US disclosed
WO-2007113833-A2 MINIMALLY INVASIVE SYSTEM FOR TREATING HOLLOW ORGAN DILATATION CAHAN AMOS (IL) 2007-10-11 WO disclosed
US-4525232-A ACRYLIC ESTER MONOMER(S), FERROCENE COMPOUND, PEROXYINITIATOR LOCTITE (IRELAND) LTD. (IE) 1985-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064350-A1 LIMONENE-BASED (METH)ACRYLATES FOR USE IN 3D PRINTING LIMK1, LIMA1, LIMK2 HPGD 1968/4885LMNA 94/4885TSHR 3518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.